{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer", "mapping knowledge domain", "natural product", "patent analysis", "traditional Chinese medicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35784720", "DateRevised": {"Year": "2023", "Month": "11", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "17"}], "Language": ["eng"], "ELocationID": ["903239", "10.3389/fphar.2022.903239"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles.", "Pagination": {"StartPage": "903239", "MedlinePgn": "903239"}, "Abstract": {"AbstractText": ["<b>Background:</b> The patent literature contains a large amount of information on the internal state of current industrial technologies that are not available in other literature studies. Scientific articles are the direct achievements of theoretical research in this field and can reveal how current theories in basic research have developed. In this study, the progress and status of natural anticancer products in this field were summarized, and the research hotspots were explored through the analysis of the relevant patent literature and scientific articles. <b>Methods:</b> Patent data were retrieved from the incoPat patent retrieval database, and paper data were retrieved from the Web of Science core set and PubMed. GraphPad Prism 8, Microsoft Excel 2010, and CiteSpace 5.8.R3 were used to perform visual processing. The analyzed patent literature includes the patent applicant type, country (or region), and technical subject. The analyzed scientific article includes academic groups, subject areas, keyword clustering, and burst detection. <b>Results:</b> A total of 20,435 patent families and 38,746 articles were collected by 4 January 2022. At present, antitumor drugs derived from natural products mainly include 1) apoptosis inducers such as curcumin, gallic acid, resveratrol, Theranekron D6, and gaillardin; 2) topoisomerase inhibitors such as camptothecins, scaffold-hopped flavones, podophyllotoxin, oxocrebanine, and evodiamine derivatives; 3) telomerase inhibitors such as camptothecin and isoquinoline alkaloids of <i>Chelidonium majus</i>, amentoflavone, and emodin; 4) microtubule inhibitors such as kolaflavanone, tanshinone IIA analog, eugenol, and millepachine; 5) immunomodulators such as fucoidan, myricetin, bergapten, and atractylenolide I; 6) tumor microenvironment regulators such as beta-escin and icaritin; 7) multidrug resistance reversal agents such as berberine, quercetin, and dihydromyricetin; and 8) antiangiogenic and antimetastatic agents such as epigallocatechin-3-gallate, lupeol, ononin, and saikosaponin A. <b>Conclusion:</b> Anticancer natural product technology was introduced earlier, but the later development momentum was insufficient. In addition, scientific research activities are relatively closed, and technical exchanges need to be strengthened. Currently, the development of medicinal plants and the research on the anticancer mechanism of natural active products are still research hotspots, especially those related to immune checkpoints, essential oils, and metastatic cancer. Theories of traditional Chinese medicine (TCM), such as \"restraining excessiveness to acquire harmony,\" \"same treatment for different diseases,\" \"Meridian induction theory,\" and \"Fuzheng Quxie,\" have important guiding significance to the research of anticancer mechanisms and the development of new drugs and can provide new ideas for this process. <b>Systematic Review Registration</b>: [https://sourceforge.net/projects/citespace/], identifier [000755430500001]."], "CopyrightInformation": "Copyright \u00a9 2022 Shen, Li, Yu and Du."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Henan University, Kaifeng, China."}], "LastName": "Shen", "ForeName": "Junkai", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Henan University, Kaifeng, China."}], "LastName": "Li", "ForeName": "Jiahuan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Henan University, Kaifeng, China."}], "LastName": "Yu", "ForeName": "Peiming", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Henan University, Kaifeng, China."}], "LastName": "Du", "ForeName": "Gangjun", "Initials": "G"}], "PublicationTypeList": ["Systematic Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abdalla A. N., Shaheen U., Abdallah Q. M. A., Flamini G., Bkhaitan M. M., Abdelhady M. I. S., et al. (2020). Proapoptotic Activity of Achillea Membranacea Essential Oil and its Major Constituent 1,8-Cineole against A2780 Ovarian Cancer Cells. Molecules 25. 10.3390/molecules25071582", "ArticleIdList": ["10.3390/molecules25071582", "PMC7180961", "32235558"]}, {"Citation": "Abdolmohammadi M. H., Fouladdel S. H., Shafiee A., Amin G. H., Ghaffari S. M., Azizi E. (2008). Anticancer Effects and Cell Cycle Analysis on Human Breast Cancer T47D Cells Treated with Extracts of Astrodaucus Persicus (Boiss.) Drude in Comparison to Doxorubicin. Daru. J. Pharm. Sci. 16, 112\u2013118. 10.1016/j.curtheres.2008.06.005", "ArticleIdList": ["10.1016/j.curtheres.2008.06.005"]}, {"Citation": "Ahuja R., Panwar N., Meena J., Singh M., Sarkar D. P., Panda A. K. (2020). Natural Products and Polymeric Nanocarriers for Cancer Treatment: a Review. Environ. Chem. Lett. 18, 2021\u20132030. 10.1007/s10311-020-01056-z", "ArticleIdList": ["10.1007/s10311-020-01056-z"]}, {"Citation": "Alrazi I. M. D., Ogunwa T. H., Kolawole A. O., Elekofehinti O. O., Omotuyi O. I., Miyanishi T., et al. (2021). Kolaflavanone, a Biflavonoid Derived from Medicinal Plant Garcinia, Is an Inhibitor of Mitotic Kinesin Eg5. J. Biochem. 170, 611\u2013622. 10.1093/jb/mvab083", "ArticleIdList": ["10.1093/jb/mvab083", "34264310"]}, {"Citation": "Arena A., Romeo M. A., Benedetti R., Masuelli L., Bei R., Gilardini Montani M. S., et al. (2021). New Insights into Curcumin- and Resveratrol-Mediated Anti-cancer Effects. Pharmaceuticals 14, 1068. 10.3390/ph14111068", "ArticleIdList": ["10.3390/ph14111068", "PMC8622305", "34832850"]}, {"Citation": "Bociort F., Macasoi I. G., Marcovici I., Motoc A., Grosu C., Pinzaru I., et al. (2021). Investigation of Lupeol as Anti-melanoma Agent: An In Vitro-In Ovo Perspective. Curr. Oncol. 28, 5054\u20135066. 10.3390/curroncol28060425", "ArticleIdList": ["10.3390/curroncol28060425", "PMC8700590", "34940064"]}, {"Citation": "Cai X.-S., Liu W.-B., Lin Y.-Y., Deng H.-B., Xu Z.-H., Li H.-Z., et al. (2022). Discussion on Pathogenesis of \u201cElements and Qi in Disorder\u201d of Cancer from \u201cHarmful Hyperactivity and Responding Inhibition\u201d and Treatment of Lung Cancer. J. Shandong Univ. TCM. 46, 20\u201324. 10.16294/j.cnki.1007-659x.2022.01.004", "ArticleIdList": ["10.16294/j.cnki.1007-659x.2022.01.004"]}, {"Citation": "\u00c7elik O., Meri\u00e7 S., Ayan A., Tas M., Avc\u0131lar C., Atak \u00c7. (2017). Magnetic Field Induced Production of Anti-cancer Agent Vincristine from Madagascar Periwinkle ( Catharanthus Roseus ) Plant. J. Biotechnol. 256, S106. 10.1016/j.jbiotec.2017.06.1163", "ArticleIdList": ["10.1016/j.jbiotec.2017.06.1163"]}, {"Citation": "Chen C. Y., Lin Y. J., Wang C. C. N., Lan Y. H., Lan S. J., Sheu M. J. (2019). Epigallocatechin-3-Gallate Inhibits Tumor Angiogenesis: Involvement of Endoglin/smad1 Signaling in Human Umbilical Vein Endothelium Cells. Biomed. PharmacotherPharmacother 120, 109491. 10.1016/j.biopha.2019.109491", "ArticleIdList": ["10.1016/j.biopha.2019.109491", "31586903"]}, {"Citation": "Cheng T., Ying M. (2021). Antitumor Effect of Saikosaponin A on Human Neuroblastoma Cells. Biomed. Res. Int. 2021, 5845554. 10.1155/2021/5845554", "ArticleIdList": ["10.1155/2021/5845554", "PMC8429005", "34513994"]}, {"Citation": "Dang Y. Y., Luo H., Li Y. M., Zhou Y., Luo X., Lin S. M., et al. (2021). Curcumin Prevents As3+-Induced Carcinogenesis through Regulation of GSK3\u03b2/Nrf2. Chin. Med. 16, 116. 10.1186/s13020-021-00527-x", "ArticleIdList": ["10.1186/s13020-021-00527-x", "PMC8582166", "34758851"]}, {"Citation": "Fan X., Deng J., Shi T., Wen H., Li J., Liang Z., et al. (2021). Design, Synthesis and Bioactivity Study of Evodiamine Derivatives as Multifunctional Agents for the Treatment of Hepatocellular Carcinoma. Bioorg. Chem. 114, 105154. 10.1016/j.bioorg.2021.105154", "ArticleIdList": ["10.1016/j.bioorg.2021.105154", "34378540"]}, {"Citation": "Ghassemi-Rad J., Maleki M., Knickle A. F., Hoskin D. W. (2018). Myricetin-induced Oxidative Stress Suppresses Murine T Lymphocyte Activation. Cell Biol. Int. 42, 1069\u20131075. 10.1002/cbin.10977", "ArticleIdList": ["10.1002/cbin.10977", "29745443"]}, {"Citation": "Gong G., Zheng Y., Kong X., Wen Z. (2021). Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway. J. Nat. Prod. 84, 1755\u20131762. 10.1021/acs.jnatprod.1c00008", "ArticleIdList": ["10.1021/acs.jnatprod.1c00008", "34029083"]}, {"Citation": "Goodwin T. E., Cousins K. R., Crane H. M., Eason P. O., Freyaldenhoven T. E., Harmon C. C., et al. (1998). Synthesis of Two New Maytansinoid Model Compounds from Carbohydrate Precursors. J. Carbohydr. Chem. 17, 323\u2013339. 10.1080/07328309808002895", "ArticleIdList": ["10.1080/07328309808002895"]}, {"Citation": "Guo H., Huang J., Li H., Yang R., Chen R. (20212021). Study on Apoptosis of Prostate Cancer Cells Induced by I\u03baB\u03b1 Overexpression Synergistic with Poly (Lactic-Co-Glycolic Acid)-Curcumin Nanoparticles. Adv. Mater. Sci. Eng. 2021, 1\u20137. 10.1155/2021/4298592", "ArticleIdList": ["10.1155/2021/4298592"]}, {"Citation": "Hong W. G., Cho J. H., Hwang S. G., Lee E., Lee J., Kim J. I., et al. (2016). Chemosensitizing Effect of Podophyllotoxin Acetate on Topoisomerase Inhibitors Leads to Synergistic Enhancement of Lung Cancer Cell Apoptosis. Int. J. Oncol. 48, 2265\u20132276. 10.3892/ijo.2016.3471", "ArticleIdList": ["10.3892/ijo.2016.3471", "PMC4863929", "27035096"]}, {"Citation": "Hu Y.-X., Chai X.-L., Zhang Z.-Q., Zhou Q.-J., Liao J.-Y. (2022). Mechanism Exploration of the Classical Traditional Chinese Medicine Formula Huoluo Xiaoling Pill in Clinical Treatment and the Traditional Chinese Medicine Theory \"Treating Different Diseases with the Same Method\": A Network Pharmacology Study and Molecular Docking Verification. World J. Tradit. Chin. Med. 8, 131\u2013140. 10.4103/wjtcm.wjtcm_58_21", "ArticleIdList": ["10.4103/wjtcm.wjtcm_58_21"]}, {"Citation": "Huang C., Li Z., Zhu J., Chen X., Hao Y., Yang R., et al. (2021). Systems Pharmacology Dissection of Epimedium Targeting Tumor Microenvironment to Enhance Cytotoxic T Lymphocyte Responses in Lung Cancer. Aging 13, 2912\u20132940. 10.18632/aging.202410", "ArticleIdList": ["10.18632/aging.202410", "PMC7880341", "33460401"]}, {"Citation": "Huang H., Yao Y., Hou G., Zhao C., Qin J., Zhang Y., et al. (2021). Design, Synthesis and Biological Evaluation of Tanshinone IIA-Based Analogues: Potent Inhibitors of Microtubule Formation and Angiogenesis. Eur. J. Med. Chem. 224, 113708. 10.1016/j.ejmech.2021.113708", "ArticleIdList": ["10.1016/j.ejmech.2021.113708", "34333396"]}, {"Citation": "Hwang J., Zhang W., Dhananjay Y., An E. K., Kwak M., You S., et al. (2021). Astragalus Membranaceus Polysaccharides Potentiate the Growth-Inhibitory Activity of Immune Checkpoint Inhibitors against Pulmonary Metastatic Melanoma in Mice. Int. J. Biol. Macromol. 182, 1292\u20131300. 10.1016/j.ijbiomac.2021.05.073", "ArticleIdList": ["10.1016/j.ijbiomac.2021.05.073", "34000307"]}, {"Citation": "Kim M., Moon A. (2022). A Curcumin Analog CA-5f Inhibits Urokinase-type Plasminogen Activator and Invasive Phenotype of Triple-Negative Breast Cancer Cells. Toxicol. Res. 38, 19\u201326. 10.1007/s43188-021-00112-2", "ArticleIdList": ["10.1007/s43188-021-00112-2", "PMC8748588", "35070937"]}, {"Citation": "Kozikowski A. P., Wang S., Ma D., Yao J., Ahmad S., Glazer R. I., et al. (1997). Modeling, Chemistry, and Biology of the Benzolactam Analogues of Indolactam V (ILV). 2. Identification of the Binding Site of the Benzolactams in the CRD2 Activator-Binding Domain of PKCdelta and Discovery of an ILV Analogue of Improved Isozyme Selectivity. J. Med. Chem. 40, 1316\u20131326. 10.1021/jm960875h", "ArticleIdList": ["10.1021/jm960875h", "9135029"]}, {"Citation": "Kubatka P., Kello M., Kajo K., Samec M., Jasek K., Vybohova D., et al. (2020). Chemopreventive and Therapeutic Efficacy of Cinnamomum Zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro Analyses. Molecules 25, 1399. 10.3390/molecules25061399", "ArticleIdList": ["10.3390/molecules25061399", "PMC7144360", "32204409"]}, {"Citation": "Lei X., Zhong Y., Huang L., Li S., Fu J., Zhang L., et al. (2020). Identification of a Novel Tumor Angiogenesis Inhibitor Targeting Shh/Gli1 Signaling Pathway in Non-small Cell Lung Cancer. Cell Death Dis. 11, 232. 10.1038/s41419-020-2425-0", "ArticleIdList": ["10.1038/s41419-020-2425-0", "PMC7156472", "32286274"]}, {"Citation": "Lengyel E., Kenny H. A., Hart P. C., Kordylewicz K., Lal M., Shen M., et al. (2021). The Natural Product \u03b2-Escin Targets Cancer and Stromal Cells of the Tumor Microenvironment to Inhibit Ovarian Cancer Metastasis. Cancers 13, 3931. 10.3390/CANCERS13163931", "ArticleIdList": ["10.3390/CANCERS13163931", "PMC8394501", "34439084"]}, {"Citation": "Li J.-X., Wang B., Yu M. (2021). Research Progress on Antitumor Mechanism of Traditional Chinese Medicine Based on Theory of \u201cFuzheng Quxie\u201d. Chin. Trad. Herb. Drugs. 52, 5751\u20135757. 10.7501/j.issn.0253-2670.2021.18.030", "ArticleIdList": ["10.7501/j.issn.0253-2670.2021.18.030"]}, {"Citation": "Li Q. W., Zhang G. L., Hao C. X., Ma Y. F., Sun X., Zhang Y., et al. (2021). SANT, a Novel Chinese Herbal Monomer Combination, Decreasing Tumor Growth and Angiogenesis via Modulating Autophagy in Heparanase Overexpressed Triple-Negative Breast Cancer. J. Ethnopharmacol. 266, 113430. 10.1016/j.jep.2020.113430", "ArticleIdList": ["10.1016/j.jep.2020.113430", "33011366"]}, {"Citation": "Li X. (2018). Discussion on Current Prevention and Treatment of Cardiovascular Diseases Difficulties Based on Theory of Harmony between Yingfen and Weifen. China J. Traditional Chin. Med. Pharm. 33, 824\u2013828."}, {"Citation": "Li Y., Guo C., Chen Q., Su Y., Guo H., Liu R., et al. (2022). Improvement of Pneumonia by Curcumin-Loaded Bionanosystems Based on Platycodon Grandiflorum Polysaccharides via Calming Cytokine Storm. Int. J. Biol. Macromol. 202, 691\u2013706. 10.1016/j.ijbiomac.2022.01.194", "ArticleIdList": ["10.1016/j.ijbiomac.2022.01.194", "35124019"]}, {"Citation": "Limtrakul P., Chearwae W., Shukla S., Phisalphong C., Ambudkar S. V. (2007). Modulation of Function of Three ABC Drug Transporters, P-Glycoprotein (ABCB1), Mitoxantrone Resistance Protein (ABCG2) and Multidrug Resistance Protein 1 (ABCC1) by Tetrahydrocurcumin, a Major Metabolite of Curcumin. Mol. Cell. Biochem. 296, 85\u201395. 10.1007/s11010-006-9302-8", "ArticleIdList": ["10.1007/s11010-006-9302-8", "16960658"]}, {"Citation": "Liu R., Liu J., Wang S., Wang Y., Zhang T., liu Y., et al. (2019). Combined Treatment with Emodin and a Telomerase Inhibitor Induces Significant Telomere Damage/Dysfunction and Cell Death. Cell Death Dis. 10, 527. 10.1038/s41419-019-1768-x", "ArticleIdList": ["10.1038/s41419-019-1768-x", "PMC6624283", "31296842"]}, {"Citation": "Ma R., Yu D., Peng Y., Yi H., Wang Y., Cheng T., et al. (2021). Resveratrol Induces AMPK and mTOR Signaling Inhibition-Mediated Autophagy and Apoptosis in Multiple Myeloma Cells. Acta Biochim. Biophys. Sin. 53, 775\u2013783. 10.1093/ABBS/GMAB042", "ArticleIdList": ["10.1093/ABBS/GMAB042", "33891090"]}, {"Citation": "Martin S. F., Limberakis C., Burgess L. E., Hartmann M. (1999). Strategies for Ansamycin Antibiotics. Asymmetric Synthesis of the C(3)-C(21) Subunit of Herbimycin A. Tetrahedron 55, 3561\u20133572. 10.1016/s0040-4020(98)01163-6", "ArticleIdList": ["10.1016/s0040-4020(98)01163-6"]}, {"Citation": "Maugeri A., Lombardo G. E., Musumeci L., Russo C., Gangemi S., Calapai G., et al. (2021). Bergamottin and 5-Geranyloxy-7-Methoxycoumarin Cooperate in the Cytotoxic Effect of Citrus Bergamia (Bergamot) Essential Oil in Human Neuroblastoma SH-Sy5y Cell Line. Toxins (Basel) 13. 10.3390/toxins13040275", "ArticleIdList": ["10.3390/toxins13040275", "PMC8069240", "33920139"]}, {"Citation": "Mehany A. B. M., Belal A., Mohamed A. F., Shaaban S., Abdelhamid G. (2022). Apoptotic and Anti-angiogenic Effects of Propolis against Human Bladder Cancer: Molecular Docking and In Vitro Screening. Biomarkers 27 (2), 138\u2013150. 10.1080/1354750X.2021.2020903", "ArticleIdList": ["10.1080/1354750X.2021.2020903", "34927500"]}, {"Citation": "Murakami A., Nakamura Y., Koshimizu K., Ohigashi H. (1995). Glyceroglycolipids from Citrus hystrix, a Traditional Herb in Thailand, Potently Inhibit the Tumor-Promoting Activity of 12-O-Tetradecanoylphorbol 13-Acetate in Mouse Skin. J. Agric. Food Chem. 43, 2779\u20132783. 10.1021/jf00058a043", "ArticleIdList": ["10.1021/jf00058a043"]}, {"Citation": "Neophytou C. M., Trougakos I. P., Erin N., Papageorgis P. (2021). Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. Cancers 13, 4363. 10.3390/cancers13174363", "ArticleIdList": ["10.3390/cancers13174363", "PMC8430856", "34503172"]}, {"Citation": "Noureini S. K., Esmaeili H., Abachi F., Khiali S., Islam B., Kuta M., et al. (2017). Selectivity of Major Isoquinoline Alkaloids from Chelidonium Majus towards Telomeric G-Quadruplex: A Study Using a Transition-FRET (T-FRET) Assay. Biochim. Biophys. Acta Gen. Subj. 1861, 2020\u20132030. 10.1016/j.bbagen.2017.05.002", "ArticleIdList": ["10.1016/j.bbagen.2017.05.002", "28479277"]}, {"Citation": "Ottaviani A., Iacovelli F., Fiorani P., Desideri A. (2021). Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB. Ijms 22, 4138. 10.3390/ijms22084138", "ArticleIdList": ["10.3390/ijms22084138", "PMC8073192", "33923641"]}, {"Citation": "Patpi S. R., Pulipati L., Yogeeswari P., Sriram D., Jain N., Sridhar B., et al. (2012). Design, Synthesis, and Structure-Activity Correlations of Novel Dibenzo[b,d]furan, Dibenzo[b,d]thiophene, and N-Methylcarbazole Clubbed 1,2,3-triazoles as Potent Inhibitors of Mycobacterium tuberculosis . J. Med. Chem. 55, 3911\u20133922. 10.1021/jm300125e", "ArticleIdList": ["10.1021/jm300125e", "22449006"]}, {"Citation": "Pourquier P., Lansiaux A. (2011). Molecular Determinants of Response to Topoisomerase II Inhibitors. Bull. Cancer 98, 1299\u20131310. 10.1684/bdc.2011.1474", "ArticleIdList": ["10.1684/bdc.2011.1474", "22023806"]}, {"Citation": "Priyadarshani G., Amrutkar S., Nayak A., Banerjee U. C., Kundu C. N., Guchhait S. K. (2016). Scaffold-hopping of Bioactive Flavonoids: Discovery of Aryl-Pyridopyrimidinones as Potent Anticancer Agents that Inhibit Catalytic Role of Topoisomerase II\u03b1. Eur. J. Med. Chem. 122, 43\u201354. 10.1016/j.ejmech.2016.06.024", "ArticleIdList": ["10.1016/j.ejmech.2016.06.024", "27343852"]}, {"Citation": "Revikumar A. (2021). Amentoflavone as a Potential Telomeric G-Quadruplex DNA Stabilizing Agent. Gene Rep. 22 (1\u20133), 100976. 10.1016/j.genrep.2020.100976", "ArticleIdList": ["10.1016/j.genrep.2020.100976"]}, {"Citation": "Roozbehani M., Abdolmohammadi M. H., Hamzeloo-Moghadam M., Irani S., Fallahian F. (2021). Gaillardin, a Potent Sesquiterpene Lactone Induces Apoptosis via Down-Regulation of NF-\u039a\u03b2 in Gastric Cancer Cells, AGS and MKN45. J. Ethnopharmacol. 281, 114529. 10.1016/j.jep.2021.114529", "ArticleIdList": ["10.1016/j.jep.2021.114529", "34418511"]}, {"Citation": "Rowaiye A. B., Mendes Y. J. T., Olofinsae S. A., Oche J. B., Oladipo O. H., Okpalefe O. A., et al. (2021). Camptothecin Shows Better Promise Than Curcumin in the Inhibition of the Human Telomerase: A Computational Study. Heliyon 7 (8), e07742. 10.1016/j.heliyon.2021.e07742", "ArticleIdList": ["10.1016/j.heliyon.2021.e07742", "PMC8405929", "34485722"]}, {"Citation": "Sanghai N., Jain V., Preet R., Kandekar S., Das S., Trivedi N., et al. (2014). Combretastatin A-4 Inspired Novel 2-Aryl-3-Arylamino-Imidazo-Pyridines/pyrazines as Tubulin Polymerization Inhibitors, Antimitotic and Anticancer Agents. Med. Chem. Commun. 5, 766\u2013782. 10.1039/c3md00357d", "ArticleIdList": ["10.1039/c3md00357d"]}, {"Citation": "Siegel R. L., Miller K. D., Fuchs H. E., Jemal A. (2022). Cancer Statistics, 2022. CA A Cancer J. Clin. 72, 7\u201333. 10.3322/caac.21708", "ArticleIdList": ["10.3322/caac.21708", "35020204"]}, {"Citation": "Sp N., Kang D. Y., Kim D. H., Park J. H., Lee H. G., Kim H. J., et al. (2018). Nobiletin Inhibits CD36-dependent Tumor Angiogenesis, Migration, Invasion, and Sphere Formation through the Cd36/Stat3/Nf-\u039ab Signaling Axis. Nutrients 10. 10.3390/nu10060772", "ArticleIdList": ["10.3390/nu10060772", "PMC6024609", "29914089"]}, {"Citation": "Suzuki Y., Ichinohe K., Sugawara A., Kida S., Murase S., Zhang J., et al. (2021). Development of Indole Alkaloid-type Dual Immune Checkpoint Inhibitors against CTLA-4 and PD-L1 Based on Diversity-Enhanced Extracts. Front. Chem. 9, 766107. 10.3389/fchem.2021.766107", "ArticleIdList": ["10.3389/fchem.2021.766107", "PMC8630621", "34858943"]}, {"Citation": "Tang Z., Dong H., Li T., Wang N., Wei X., Wu H., et al. (20212021). The Synergistic Reducing Drug Resistance Effect of Cisplatin and Ursolic Acid on Osteosarcoma through a Multistep Mechanism Involving Ferritinophagy. Oxidative Med. Cell. Longev. 2021, 1\u201317. 10.1155/2021/5192271", "ArticleIdList": ["10.1155/2021/5192271", "PMC8714329", "34970416"]}, {"Citation": "Teng J. F., Mei Q. B., Zhou X. G., Tang Y., Xiong R., Qiu W. Q., et al. (2020). Polyphyllin VI Induces Caspase-1-Mediated Pyroptosis via the Induction of ROS/NF-\u03baB/NLRP3/GSDMD Signal Axis in Non-small Cell Lung Cancer. Cancers (Basel) 12. 10.3390/cancers12010193", "ArticleIdList": ["10.3390/cancers12010193", "PMC7017302", "31941010"]}, {"Citation": "Thakkar P. V., Kita K., Castillo U. D., Galletti G., Madhukar N., Navarro E. V., et al. (2021). CLIP-170S Is a Microtubule +TIP Variant that Confers Resistance to Taxanes by Impairing Drug-Target Engagement. Dev. Cell. 56, 3264\u2013e7. 10.1016/j.devcel.2021.09.023", "ArticleIdList": ["10.1016/j.devcel.2021.09.023", "PMC8665049", "34672971"]}, {"Citation": "Tong Y., Zhang J., Sun N., Wang X.-M., Wei Q., Zhang Y., et al. (2021). Berberine Reverses Multidrug Resistance in candida Albicans by Hijacking the Drug Efflux Pump Mdr1p. Sci. Bull. 66, 1895\u20131905. 10.1016/j.scib.2020.12.035", "ArticleIdList": ["10.1016/j.scib.2020.12.035", "36654399"]}, {"Citation": "Tosun N. G., Kaplan \u00d6., \u00d6zg\u00fcr A. (2021). Apoptosis Induced by Tarantula Cubensis Crude Venom (Theranekron D6) in Cancer Cells. Rev. Bras. Farmacogn. 31, 824\u2013831. 10.1007/s43450-021-00221-x", "ArticleIdList": ["10.1007/s43450-021-00221-x"]}, {"Citation": "Tripathi S. K., Panda M., Biswal B. K. (2019). Emerging Role of Plumbagin: Cytotoxic Potential and Pharmaceutical Relevance towards Cancer Therapy. Food Chem. Toxicol. 125, 566\u2013582. 10.1016/j.fct.2019.01.018", "ArticleIdList": ["10.1016/j.fct.2019.01.018", "30685472"]}, {"Citation": "Wang L., Fang K., Cheng J., Li Y., Huang Y., Chen S., et al. (2020). Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer. J. Med. Chem. 63, 696\u2013713. 10.1021/acs.jmedchem.9b01626", "ArticleIdList": ["10.1021/acs.jmedchem.9b01626", "31880942"]}, {"Citation": "Wang Y., Zhong J., Bai J., Tong R., An F., Jiao P., et al. (2018). The Application of Natural Products in Cancer Therapy by Targeting Apoptosis Pathways. Curr. Drug Metab. 19, 739\u2013749. 10.2174/1389200219666180511154722", "ArticleIdList": ["10.2174/1389200219666180511154722", "29749309"]}, {"Citation": "Wang Z., Liu F., Liao W., Yu L., Hu Z., Li M., et al. (2020). Curcumin Suppresses Glioblastoma Cell Proliferation by P-AKT/mTOR Pathway and Increases the PTEN Expression. Arch. Biochem. Biophys. 689, 108412. 10.1016/j.abb.2020.108412", "ArticleIdList": ["10.1016/j.abb.2020.108412", "32445778"]}, {"Citation": "Wang Z., Sun X., Feng Y., Wang Y., Zhang L., Wang Y., et al. (2021). Dihydromyricetin Reverses MRP2-Induced Multidrug Resistance by Preventing NF-\u03baB-Nrf2 Signaling in Colorectal Cancer Cell. Phytomedicine 82, 153414. 10.1016/j.phymed.2020.153414", "ArticleIdList": ["10.1016/j.phymed.2020.153414", "33461143"]}, {"Citation": "Wayne J., Brooks T., Landras A., Massey A. J. (2021). Targeting DNA Damage Response Pathways to Activate the Sting Innate Immune Signaling Pathway in Human Cancer Cells. FEBS J. 288, 4507\u20134540. 10.1111/febs.15747", "ArticleIdList": ["10.1111/febs.15747", "33529438"]}, {"Citation": "Xie Z., Wen T., Zhang Z., Huang K., Wu T., Liu J., et al. (2018). Immuno Modulatory Effects of Bergapten Attenuates D-Galactose-Induced Aging Model in Balb/C Mice. Int. J. Pharmacol. 14, 936\u2013944. 10.3923/ijp.2018.936.944", "ArticleIdList": ["10.3923/ijp.2018.936.944"]}, {"Citation": "Xin L. T., Liu L., Shao C. L., Yu R. L., Chen F. L., Yue S. J., et al. (2017). Discovery of DNA Topoisomerase I Inhibitors with Low-Cytotoxicity Based on Virtual Screening from Natural Products. Mar. Drugs 15. 10.3390/md15070217", "ArticleIdList": ["10.3390/md15070217", "PMC5532659", "28698495"]}, {"Citation": "Xu H., Van der Jeught K., Zhou Z., Zhang L., Yu T., Sun Y., et al. (2021). Atractylenolide I Enhances Responsiveness to Immune Checkpoint Blockade Therapy by Activating Tumor Antigen Presentation. J. Clin. Invest. 131. 10.1172/jci146832", "ArticleIdList": ["10.1172/jci146832", "PMC8121519", "33830945"]}, {"Citation": "Yan F., Wang X., Xie Y., Liu X., Yu L., Wang P., et al. (2021). Yangyin Fuzheng Jiedu Prescription Exerts Anti-tumor Immunity in Hepatocellular Carcinoma by Alleviating Exhausted T Cells. Phytomedicine 91, 153722. 10.1016/j.phymed.2021.153722", "ArticleIdList": ["10.1016/j.phymed.2021.153722", "34488188"]}, {"Citation": "Yan J., Zhuang Q., Li Z., Xiong Y., He M., Kang C., et al. (2021). MIL-1, a Novel Antitumor Agent Derived from Natural Product Millepachine, Acts as Tubulin Polymerization Inhibitor for the Treatment of Hepatocellular Carcinoma. Eur. J. Pharmacol. 898, 173975. 10.1016/j.ejphar.2021.173975", "ArticleIdList": ["10.1016/j.ejphar.2021.173975", "33647258"]}, {"Citation": "Yang C., Li Y., Fu L., Jiang T., Meng F. (2018). Betulinic Acid Induces Apoptosis and Inhibits Metastasis of Human Renal Carcinoma Cells In Vitro and In Vivo . J. Cell. Biochem. 119, 8611\u20138622. 10.1002/jcb.27116", "ArticleIdList": ["10.1002/jcb.27116", "29923216"]}, {"Citation": "Yang J., Yang X., Pan W., Wang M., Lu Y., Zhang J., et al. (2021). Fucoidan-Supplemented Diet Potentiates Immune Checkpoint Blockage by Enhancing Antitumor Immunity. Front. Cell Dev. Biol. 9. 10.3389/fcell.2021.733246", "ArticleIdList": ["10.3389/fcell.2021.733246", "PMC8382313", "34434936"]}, {"Citation": "Yu L., Han S., Lang L., Song H., Zhang C., Dong L., et al. (2021). Oxocrebanine: A Novel Dual Topoisomerase Inhibitor, Suppressed the Proliferation of Breast Cancer Cells MCF-7 by Inducing DNA Damage and Mitotic Arrest. Phytomedicine 84, 153504. 10.1016/j.phymed.2021.153504", "ArticleIdList": ["10.1016/j.phymed.2021.153504", "33611211"]}, {"Citation": "Yuan L. W., Jiang X. M., Xu Y. L., Huang M. Y., Chen Y. C., Yu W. B., et al. (2021). Licochalcone A Inhibits Interferon-Gamma-Induced Programmed Death-Ligand 1 in Lung Cancer Cells. Phytomedicine 80, 153394. 10.1016/j.phymed.2020.153394", "ArticleIdList": ["10.1016/j.phymed.2020.153394", "33130472"]}, {"Citation": "Zehra B., Ahmed A., Sarwar R., Khan A., Farooq U., Abid Ali S., et al. (2019). Apoptotic and Antimetastatic Activities of Betulin Isolated from Quercus Incana against Non-small Cell Lung Cancer Cells. Cancer Manag. Res. 11, 1667\u20131683. 10.2147/cmar.S186956", "ArticleIdList": ["10.2147/cmar.S186956", "PMC6388989", "30863176"]}, {"Citation": "Zhao J., Lan W., Peng J., Guan B., Liu J., Zhang M., et al. (20212021). Babao Dan Reverses Multiple-Drug Resistance in Gastric Cancer Cells via Triggering Apoptosis and Autophagy and Inhibiting PI3K/AKT/mTOR Signaling. Evidence-Based Complementary Altern. Med. 2021, 1\u201313. 10.1155/2021/5631942", "ArticleIdList": ["10.1155/2021/5631942", "PMC8285167", "34306145"]}, {"Citation": "Zhou Y., Zhang J., Wang K., Han W., Wang X., Gao M., et al. (2020). Quercetin Overcomes Colon Cancer Cells Resistance to Chemotherapy by Inhibiting Solute Carrier Family 1, Member 5 Transporter. Eur. J. Pharmacol. 881, 173185. 10.1016/j.ejphar.2020.173185", "ArticleIdList": ["10.1016/j.ejphar.2020.173185", "32422185"]}, {"Citation": "Zhu D., Lyu M., Jiang W., Suo M., Huang Q., Li K. (2020). A Biomimetic Nanozyme/Camptothecin Hybrid System for Synergistically Enhanced Radiotherapy. J. Mater Chem. B 8, 5312\u20135319. 10.1039/d0tb00676a", "ArticleIdList": ["10.1039/d0tb00676a", "32453333"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "24"}, {"Year": "2022", "Month": "5", "Day": "2"}, {"Year": "2022", "Month": "7", "Day": "5", "Hour": "10", "Minute": "29"}, {"Year": "2022", "Month": "7", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["35784720", "PMC9247190", "10.3389/fphar.2022.903239", "903239"]}}], "PubmedBookArticle": []}